← Evidence map

ArticleIranian journal of pharmaceutical research : IJPR2022

Potential Benefits of

Sry Suryani Widjaja et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2022
2023
2024
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36896315